CN117561328A - iPS细胞来源的软骨细胞结构体的制造方法 - Google Patents

iPS细胞来源的软骨细胞结构体的制造方法 Download PDF

Info

Publication number
CN117561328A
CN117561328A CN202280045456.2A CN202280045456A CN117561328A CN 117561328 A CN117561328 A CN 117561328A CN 202280045456 A CN202280045456 A CN 202280045456A CN 117561328 A CN117561328 A CN 117561328A
Authority
CN
China
Prior art keywords
chondrocytes
stem cells
day
dimensional structure
differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280045456.2A
Other languages
English (en)
Chinese (zh)
Inventor
中山功一
安娜·玛利亚·中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saga University NUC
Original Assignee
Saga University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saga University NUC filed Critical Saga University NUC
Publication of CN117561328A publication Critical patent/CN117561328A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00—Processes of additive manufacturing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
CN202280045456.2A 2021-06-29 2022-06-28 iPS细胞来源的软骨细胞结构体的制造方法 Pending CN117561328A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-107656 2021-06-29
JP2021107656 2021-06-29
PCT/JP2022/026536 WO2023277195A1 (ja) 2021-06-29 2022-06-28 ｉＰＳ細胞由来軟骨細胞構造体の製造方法

Publications (1)

Publication Number Publication Date
CN117561328A true CN117561328A (zh) 2024-02-13

Family

ID=84692811

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280045456.2A Pending CN117561328A (zh) 2021-06-29 2022-06-28 iPS细胞来源的软骨细胞结构体的制造方法

Country Status (5)

Country Link
US (1) US20240294877A1 (https=)
EP (1) EP4365281A4 (https=)
JP (1) JP7716773B2 (https=)
CN (1) CN117561328A (https=)
WO (1) WO2023277195A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1031503B1 (fr) * 2023-04-14 2024-11-13 Novadip Biosciences Composition comprenant une matrice extracellulaire neo-synthesisée déivée de cellules stem pluripotentes induites (ipsc)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
CN101679947B (zh) 2007-03-30 2013-03-06 国立大学法人九州大学 细胞立体构造体的生产方法
JP2020202785A (ja) * 2019-06-17 2020-12-24 株式会社サイフューズ 細胞立体構造体及びその製造方法

Also Published As

Publication number Publication date
EP4365281A4 (en) 2025-07-16
EP4365281A1 (en) 2024-05-08
JPWO2023277195A1 (https=) 2023-01-05
JP7716773B2 (ja) 2025-08-01
WO2023277195A1 (ja) 2023-01-05
US20240294877A1 (en) 2024-09-05

Similar Documents

Publication Publication Date Title
Ferretti et al. Periosteum derived stem cells for regenerative medicine proposals: Boosting current knowledge
Sui et al. Mesenchymal condensation in tooth development and regeneration: a focus on translational aspects of organogenesis
T Brown et al. Stem cell-based tissue engineering approaches for musculoskeletal regeneration
US11976296B2 (en) Means and methods for generating midbrain organoids
CN1227356C (zh) 脂肪组织衍生的基质细胞的用途
JP2022188229A (ja) 中間中胚葉細胞から腎前駆細胞への分化誘導方法、および多能性幹細胞から腎前駆細胞への分化誘導方法
JP5700301B2 (ja) 多能性幹細胞からの神経堤細胞群の分化誘導方法
Illich et al. Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration
Xing et al. Osteogenic differentiation evaluation of an engineered extracellular matrix based tissue sheet for potential periosteum replacement
KR20160068982A (ko) 신규 연골 세포 유도 방법
Mesallati et al. Engineering cartilaginous grafts using chondrocyte‐laden hydrogels supported by a superficial layer of stem cells
Pokrywczynska et al. Mesenchymal stromal cells modulate the molecular pattern of healing process in tissue-engineered urinary bladder: the microarray data
JPWO2019177118A1 (ja) 多能性幹細胞から各種細胞への段階的製造方法
CN118475685A (zh) 神经嵴细胞的培养方法及制造方法
JP7716773B2 (ja) ｉＰＳ細胞由来軟骨細胞構造体の製造方法
KR102014020B1 (ko) 원심분리를 통한 세포 크기별 분리를 이용하여 분화 유도된 연골세포
Su et al. Recent Research on Chondrocyte Dedifferentiation and Insights for Regenerative Medicine
Guzzo et al. Human pluripotent stem cells: advances in chondrogenic differentiation and articular cartilage regeneration
Foltz et al. Craniofacial cartilage organoids from human embryonic stem cells via a neural crest cell intermediate
CN117398525B (zh) 表达Exendin-4蛋白的间充质干细胞及其用途
Fu et al. Potential replication of induced pluripotent stem cells for craniofacial reconstruction
WO2023133726A1 (en) Human urine-derived induced presomitic mesoderm progenitor cells and uses thereof
JP6785516B2 (ja) ヒト臍帯由来間葉系幹細胞から骨芽細胞の製造を目的としたアクチン重合阻害剤による分化誘導技術
KR20100061605A (ko) 중간엽 줄기세포로부터의 연골화분화 방법 및 이에 의해 분화된 연골발생세포를 포함하는 연골손상 질환 치료용 조성물
Nakayama et al. From pluripotent stem cells to lineage-specific chondrocytes: essential signalling and cellular intermediates

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination